AC

Ayrton Capital

North America, Connecticut, United States, Westport

Description

Ayrton Capital operates as an investment firm.

Investor Profile

Ayrton Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ayrton Capital frequently co-invest with?

Altium Capital
North America, New York, United States, New York
Co-Investments: 1
D2
North America, Indiana, United States, Huntington
Co-Investments: 1
Lincoln Park Capital Fund
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Ayrton Capital?

Ocuphire Pharma

Farmington Hills, Michigan, United States

Ocuphire Pharma, a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityJun 8, 2021
Amount Raised: $15,000,000